Similarly, a study published just last week found that semaglutide, as well as Eli Lillys GLP-1 tirzepatide (Zepbound for weight loss), is associated with significantly lower risks of dementia and stroke
Targeted medications A prescription medication to treat vasomotor (hot flash) symptoms, called fezolinetant, comes with a bonus benefit: lessening sleep disruptions
Adding a new variable when your thyroid is already unstable makes management significantly harder
They even decreased the risk of death in people with diabetes and heart disease
The clinical research and emerging data on tirzepatide-based compounds, including GLP-1 GIP B12 formulations, point to a range of metabolic, cardiovascular, and anti-inflammatory benefits that extend well beyond the number on the scale